AstraZeneca Requests FDA Approval for Self-Administered Nasal Flu Vaccine

Gizmodo

AstraZeneca submitted a request for the FDA on Wednesday to approve a self-administered nasal flu vaccine for people ages two to 49 years old.

Subscribe to live attenuated influenza vaccine